[go: up one dir, main page]

JPS61187793A - Plasmid DNA separation and purification method - Google Patents

Plasmid DNA separation and purification method

Info

Publication number
JPS61187793A
JPS61187793A JP60027419A JP2741985A JPS61187793A JP S61187793 A JPS61187793 A JP S61187793A JP 60027419 A JP60027419 A JP 60027419A JP 2741985 A JP2741985 A JP 2741985A JP S61187793 A JPS61187793 A JP S61187793A
Authority
JP
Japan
Prior art keywords
dna
plasmid dna
rna
filtration chromatography
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60027419A
Other languages
Japanese (ja)
Inventor
Osanori Numao
沼尾 長徳
Hiroyuki Narishima
成島 裕之
Hitoshi Kakiya
均 柿谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nippon Soda Co Ltd
Nissan Chemical Corp
Sagami Chemical Research Institute
Tosoh Corp
Original Assignee
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nippon Soda Co Ltd
Nissan Chemical Corp
Sagami Chemical Research Institute
Toyo Soda Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Glass Co Ltd, Hodogaya Chemical Co Ltd, Nippon Soda Co Ltd, Nissan Chemical Corp, Sagami Chemical Research Institute, Toyo Soda Manufacturing Co Ltd filed Critical Central Glass Co Ltd
Priority to JP60027419A priority Critical patent/JPS61187793A/en
Publication of JPS61187793A publication Critical patent/JPS61187793A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:A cyclic double-stranded DNA containing RNA and other DNA is subjected to a specific gel filtration chromatography to effect short-time and economical isolation and purification of the titled DNA. CONSTITUTION:A cyclic double-stranded DNA containing other components is previously treated with ribonuclease to digest a part of RNA, then subjected to gel filtration chromatography of spherical, hydrophilic semirigid vinyl polymer gel which has hydroxyl groups and ether groups on its side chains and swells in aqueous solutions, more than 1,000Angstrom average pore diameter and less than 100mum average particle size using, as an eluate, an aqueous solution of 7.0-8.5pH, containing 2-500mM of tris hydrochloride, 1-50mM of EDTA and 10-1,000mM of NaCl to separate and purify a plasmid DNA of 3-12Kbp.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はプラスミドDNAの分離精製方法に関するもの
であり、さらに詳しくはr/I/濾過クロマトグラフィ
な用いて環状二重鎖DNAをRNA及び他のDNAから
分離精製するプラスミドDNAの分離精製方法に関する
ものである。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for separating and purifying plasmid DNA. This invention relates to a method for separating and purifying plasmid DNA from DNA.

〔従来の技術〕[Conventional technology]

プラスミドDNAは遺伝子操作の分野での重要な材料で
あり、通常微生物の菌体を溶菌して得た溶液から分離精
製することにより得られる。
Plasmid DNA is an important material in the field of genetic engineering, and is usually obtained by separating and purifying a solution obtained by lysing the cells of a microorganism.

プラスミドDNAを分離精製する方法、特にプラスミド
DNAをRNAや染色体DNAなどから分離するために
従来より一般に用いられてきた方法は、エチジウムブロ
マイドとの間の親和性の差の結果生じる密度の違いを利
用したエチジウムブロマイド−塩化セシウム平衡密度勾
配超遠心法であった。
The method that has been commonly used in the past to separate and purify plasmid DNA, particularly to separate plasmid DNA from RNA and chromosomal DNA, utilizes the difference in density resulting from the difference in affinity between plasmid DNA and ethidium bromide. Ethidium bromide-cesium chloride equilibrium density gradient ultracentrifugation was performed.

しかしながらこの方法は、超遠心機の運転やエチジウム
ブロマイドおよび塩化セシウムの除去に長時間を要する
こと、塩化セシウムが高価でしかも再利用が困難である
こと、超遠心機を長時間連続運転するために運転コスト
および危険性が無視できないこと、発ガン物質として知
られているエチジウムブロマイドを高濃度で使用するた
め人体に害を及ばずおそれがあること、などの欠点を有
している。
However, this method requires a long time to operate the ultracentrifuge and remove ethidium bromide and cesium chloride, and cesium chloride is expensive and difficult to reuse. It has drawbacks such as non-negligible operating costs and risks, and the use of ethidium bromide, a known carcinogen, in high concentrations, which may pose no harm to the human body.

最近になって、高分子量物質を分子フルイの原理に基い
て分画するためのカラムクロミドグラフィー用担体の開
発が進み、これをシラスミドDNAの精製に使用したと
いう報告がいくつかなされている。それらで用いられて
いる方法は例えば、(1)  アガロースダル濾過担体
とナトリウムアジドを含むトリス塩酸−EDTA −N
aCL水性溶出液との組合せ〔リリス他(M−Lsll
is at *1m )、アナリテカルバイオケミスト
リ−(AnalyticalBioch@m1stry
 )、120巻、52−58頁(1982)’l、(2
)  アガロースダル濾過担体とトリス塩酸−EDTA
−NaC1水性溶出液との組合せ〔ホルムス(D、S。
Recently, there has been progress in developing carriers for column chromidography for fractionating high molecular weight substances based on the principle of molecular sieves, and there have been several reports of their use in purifying cilasmid DNA. The methods used therein include, for example, (1) Tris-HCl-EDTA-N containing agarose dal filtration carrier and sodium azide;
Combination with aCL aqueous eluate [Lillis et al.
is at *1m), Analytical Bioch@m1stry
), vol. 120, pp. 52-58 (1982)'l, (2
) Agarose dal filtration carrier and Tris-HCl-EDTA
- combination with NaCl aqueous eluate [Holmus (D, S.

Holmea ) 、アナリテカルパイオケミストリ−
(Analytical Biochemlstry 
)、127巻、428−433頁(1982))、 (3)  大きな網目構造を持つ成極の?リマー・ダル
とNa(’tを含むトリスリン酸溶出液との組合せ〔パ
イウォーター他(R++ Byvater et al
 )、フ7 /L/ マシャジャパン(株)商品カタロ
グ、1983年3月〕り(4)アリルデキストラン−N
、N’−メチレンビスアクリルアミド架橋ダルを用いる
方法〔♂ロス他(Boro@、 I at at、 )
 、ゾーン(Gone )、22巻、191−201頁
(1983)]、 などが知られている。
Holmea), Analytical Biochemistry
(Analytical Biochemistry
), vol. 127, pp. 428-433 (1982)), (3) polarization with a large network structure? Combination of Limar Dal and Tris phosphate eluate containing Na('t) [Byvater et al.
), F7 /L/ Masha Japan Co., Ltd. Product Catalog, March 1983] Ri(4) Allyldextran-N
, a method using N'-methylenebisacrylamide crosslinked resin [♂Ross et al. (Boro@, I at at, )
, Gone, Vol. 22, pp. 191-201 (1983)].

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

これらの公知方法では、なお環状二重鎖DNAの染色体
DNA等からの分離が必ずしも充分でなく、一層の改良
が望まれていた。
In these known methods, the separation of circular double-stranded DNA from chromosomal DNA, etc. is not always sufficient, and further improvements have been desired.

〔問題を解決するための手段及び作用〕本発明は特定の
rル担体と特定の溶出液を組合せる方法を鋭意検討した
結果、この問題を解決したものである。即ち本発明は、
共存成分としてRNA及び他のDNAを含む環状二重鎖
DNAを、トリス塩酸塩、EDTA及び塩化す) IJ
ウムを含むpi(約7、0ないし約8.5の水性展開液
を用−て、側鎖にヒドロキシル基及びエーテル結合を有
し、水溶液中で膨潤する親水性半硬質架橋ビニル、N 
IJママ−ダル上r/L/濾過クロマトグラフィに付す
ることを特徴とする!ラスミドDNAの分離精製方法を
提供するものである。
[Means and effects for solving the problem] The present invention has solved this problem as a result of intensive study on a method of combining a specific carrier and a specific eluent. That is, the present invention
Circular double-stranded DNA containing RNA and other DNA as coexisting components is treated with Tris hydrochloride, EDTA and salt) IJ
Hydrophilic semi-rigid cross-linked vinyl having hydroxyl groups and ether bonds in side chains and swells in aqueous solution, N
It is characterized by being subjected to r/L/filtration chromatography on IJ Mama Dal! A method for separating and purifying lasmid DNA is provided.

用−る親水性半硬質ビニルポリマーゲルとしては約50
01.好ましくは約1,000Å以上の巨大平均細孔径
と約1004m以下の平均粒子径を有する球状ダルであ
ることが好ましい。平均細孔径の上限としては、限定的
ではないが、約1×104^程度である。ま九各粒子の
細孔径はできるだけ均一であることが好ましい。平均粒
子径の下限は格別にないが、あまりに小さいとクロマト
グラフィに長時間を要する(又は高圧を用いる必要があ
る)ので実用的には約35城程度である。各粒子の粒子
径もまた、できるだけ均一であることが好ましい。
The hydrophilic semi-rigid vinyl polymer gel used is approximately 50
01. Preferably, it is a spherical colloid having a giant average pore diameter of about 1,000 Å or more and an average particle diameter of about 1004 m or less. Although the upper limit of the average pore diameter is not limited, it is approximately 1×10 4 ^. It is preferable that the pore diameter of each particle be as uniform as possible. There is no particular lower limit to the average particle diameter, but if it is too small, chromatography will take a long time (or high pressure will need to be used), so it is practically about 35 mm. It is also preferable that the particle diameter of each particle is as uniform as possible.

この様な親水性硬質ビニル架橋?リフーゲルとしては、
例えばToyop*arl (登録商標、東洋曹達工業
株式会社製)HW−758をあげることができる。
Hydrophilic hard vinyl cross-linked like this? As a refugel,
For example, Toyop*arl (registered trademark, manufactured by Toyo Soda Kogyo Co., Ltd.) HW-758 can be mentioned.

本発明で、親水性硬質ビニルポリマーゲルはカラムに充
填し、通常の液体クロマトグラフィの手法によりて用い
ることができるう 本発明ではクロマトグラフィの展開・溶出液としてトリ
ス塩酸塩、T:DTA及び塩化ナトリウムを含む声部7
.0なりし約、8.5水性緩衝溶液を用いる。
In the present invention, the hydrophilic hard vinyl polymer gel can be packed into a column and used by ordinary liquid chromatography techniques. Including voice part 7
.. 8.5 aqueous buffer solution is used.

この溶液中のトリス塩酸塩の濃度は約2ないし約500
mM程度、好ましくは約10ないし約Zo。
The concentration of Tris hydrochloride in this solution is about 2 to about 500
On the order of mM, preferably about 10 to about Zo.

mM程度である。EDTAの濃度は約1な−し約50城
程度、好ましくは約2ないし約20mM程度である。ま
た塩化ナトリウムの濃度は約10ないし約1004m以
下度、好ましくは約50ないし約500 mM程度であ
る。
It is about mM. The concentration of EDTA is about 1 to about 50 mM, preferably about 2 to about 20 mM. The concentration of sodium chloride is about 10 to about 1004mM or less, preferably about 50 to about 500mM.

本発明で分離精製することのできる環状二重鎖DNAは
約3ないし約12kb程度の大きさのものでおる。
The circular double-stranded DNA that can be separated and purified by the present invention has a size of about 3 to about 12 kb.

本発明で用いる、環状二重鎖DNAをRNA及び他のD
NAとともに含む試料は、この様な環状二重鎖DNAを
持つ微生物菌体をリゾチーム等で処理して溶菌させ、得
られるクリヤード・リゼートを煮沸法〔ホルムス(Ho
lmes、 D、S−)、アナリテカルケミストリー(
Analytical Ch@m1stry )、12
7巻、428−433頁〕、フェノール抽出法、イング
ロノ母ノール沈殿法、エタノール沈殿法等によって蛋白
質、リピド等から分離し、適当な緩衝液に溶解するとと
によって得ることができる。
The circular double-stranded DNA used in the present invention can be combined with RNA and other D
The sample containing NA is obtained by treating microbial cells with such circular double-stranded DNA with lysozyme, etc. to lyse them, and then boiling the resulting clarified lysate.
lmes, D, S-), Analytical Chemistry (
Analytical Ch@m1stry), 12
7, pp. 428-433], by separating it from proteins, lipids, etc. by a phenol extraction method, an ethanol precipitation method, an ethanol precipitation method, etc., and dissolving it in an appropriate buffer.

本発明ではこの様な試料をあらかじめリボヌクレアーゼ
Aで処理してRNAの可成りの部分を消化したのち、ダ
yf−過クロマトグラフィに付することKよって!ラス
ミドDNAの分離精製をさらに効果的忙行うことができ
る。
In the present invention, such a sample is treated with ribonuclease A in advance to digest a considerable portion of the RNA, and then subjected to dyf-perchromatography. Separation and purification of lasmid DNA can be carried out more effectively and efficiently.

〔実施例〕〔Example〕

実施例1 試料調製例1で得たpna 322プラスミドを含む試
料を、20nMのトリス塩酸塩、10城のEDTA及び
100 mMのNaC1を含むp)17.5の緩衝溶液
IR1に溶解し、Toyopearl (登録商標:前
出)HW−758をダル担体としてrル濾過クロマトグ
ラフィを行った。条件は以下の通りであった。なお検出
は各実施例および比較例とも254 nmでの吸光度測
定によった・ カラム:1.5譚X30m×2 各画分のJl:60滴 溶出圧カニ約5.0kg!/α2 溶出速度:36ffi//時間 得られたクロマトグラムを第1図に示す。第1図中1は
染色体DNAの、同2はプラスミドDNAの、3はRN
Aの各−一りを示す。第2図は各フラクシlンのアガロ
ースゲル上での電気泳動像を示す。
Example 1 The sample containing the pna 322 plasmid obtained in Sample Preparation Example 1 was dissolved in p) 17.5 buffer solution IR1 containing 20 nM Tris-hydrochloride, 10 molar EDTA, and 100 mM NaCl, and dissolved in Toyopearl ( (Registered Trademark: Previous) Relfiltration chromatography was performed using HW-758 as a dull carrier. The conditions were as follows. Detection was carried out by absorbance measurement at 254 nm in both Examples and Comparative Examples Column: 1.5 mm x 30 m x 2 Jl of each fraction: 60 drops Elution pressure: about 5.0 kg! /α2 Elution rate: 36ffi//hour The obtained chromatogram is shown in FIG. In Figure 1, 1 is chromosomal DNA, 2 is plasmid DNA, and 3 is RN.
Each of A indicates one. FIG. 2 shows electrophoretic images of each fraxin on an agarose gel.

溶出液の各フラクション10μLを0.747Iロース
rル電気泳動に供した。第2図にその泳動・やターンを
示す。フラクション番号26.28及び30には染色体
DNAが、tた7ラクシ、ン番号34.36,38及び
40にはプラスミドDNAが。
10 μL of each eluate fraction was subjected to 0.747 I low flow electrophoresis. Figure 2 shows its migration and turns. Fraction numbers 26, 28 and 30 contained chromosomal DNA, and fraction numbers 34, 36, 38 and 40 contained plasmid DNA.

さらにフラクション番号52,54,56及び58には
RNAが主成分として含まれていることが示される。ま
た分子量マーカー(1)としてλ−ファージDNAのH
lnd m消化物を、また分子マーカー(2)(標準〕
として、その二毫体を含むpBR322プラスミドを用
いた。
Furthermore, it is shown that fraction numbers 52, 54, 56, and 58 contain RNA as a main component. In addition, H of λ-phage DNA is used as a molecular weight marker (1).
lnd m digest and molecular marker (2) (standard)
The pBR322 plasmid containing the dimorphism was used as a pBR322 plasmid.

実施例2 試料調製例2で得たptyc 8プラスミドを含む試料
を、10rrMトリス塩酸塩、1 mM EDTAを含
む−8,0の溶液(以下TI緩衝液と云う)1dに溶解
した。
Example 2 The sample containing the ptyc 8 plasmid obtained in Sample Preparation Example 2 was dissolved in -8.0 solution (hereinafter referred to as TI buffer) 1d containing 10rrM Tris hydrochloride and 1mM EDTA.

固定化リボヌクレアーゼA(シグマ社製、Ribonu
cleas@As R−4001sウシ膵臓由来の不溶
性酵素をアガロースビーズに担持させたもの)5単位を
水で数回洗浄した後、水で膨潤させたセファデックス(
5ephadsx商標)G−251,7mjを加えてカ
ラムに充填した。
Immobilized ribonuclease A (manufactured by Sigma, Ribonu
cleas@As R-4001s Insoluble enzyme derived from bovine pancreas supported on agarose beads) 5 units were washed several times with water, and then Sephadex swollen with water (
5ephadsx trademark) G-251,7mj was added and packed into the column.

カラムをTI緩衝液で平衡化し、これに試料溶液を通過
させTE緩衝液で洗浄した。通過液12−からDNA成
分を沈殿させ、沈殿を実施例1と同じ溶出用緩衝液1d
に溶解し、Toyopearl (登録商標:前出)H
W−758をゲル担体としてrル濾過クロマトグラフィ
を行った。条件は以下の通りでありたO カラム:1.5cIgIX46clR 各画分の量:40滴 溶出圧カニ静水圧90備 溶出速度: 12 WLl/hr。
The column was equilibrated with TI buffer, and the sample solution was passed through it and washed with TE buffer. Precipitate the DNA component from the passthrough 12-, and add the precipitate to the same elution buffer 1d as in Example 1.
Dissolved in Toyopearl (registered trademark: supra) H
Relfiltration chromatography was performed using W-758 as a gel carrier. The conditions were as follows: O Column: 1.5 cIgIX46clR Amount of each fraction: 40 drops Elution pressure: Crab hydrostatic pressure: 90 Elution rate: 12 WLl/hr.

得られたクロマトグラムを第3図疋示す。第3図中、1
.2及び3は第1図中でのそれらと同じ意味を表わす。
The obtained chromatogram is shown in Figure 3. In Figure 3, 1
.. 2 and 3 have the same meaning as in FIG.

実施例3 実施例2で用いたと同じ固定化リボヌクレアーゼAのカ
ラムとToyopearl (登録商標:前出)のカラ
ムを前者の溶出液が後者に流入する様に連結した。両力
ラムを実施例1で用いたと同じ溶出液で平衡化したのち
、これに試料調製例2と同様にして得たpUC8プラス
ミドを含む試料をこの溶出液1dK溶解して固定化リコ
ヌクレアーゼAのカラムに注入し、この溶出液を用いて
リボヌクレアーゼAKよる消化とToyopearl 
(登録商標:前出)HW−75S によるダル濾過クロ
マトグラフィを同時に行った。溶出条件は以下の通りで
あった。
Example 3 The same immobilized ribonuclease A column used in Example 2 and the Toyopearl (registered trademark) column were connected so that the eluate from the former would flow into the latter. After equilibrating the Ryoriki Ram with the same eluate used in Example 1, a sample containing the pUC8 plasmid obtained in the same manner as in Sample Preparation Example 2 was dissolved in this eluate by 1 dK, and the immobilized reconuclease A was dissolved. The eluate was used for digestion with ribonuclease AK and Toyopearl.
(registered trademark: supra) Dull filtration chromatography using HW-75S was performed at the same time. The elution conditions were as follows.

各画分の量: 40滴 溶出圧カニ静水圧90cIn 溶出速度=12ゴ/hr− 得られたクロマトグラムを第4図に示す。第4図中1,
2及び3は第1図中でのそれらと同じ意味を表わす。
Amount of each fraction: 40 drops Elution pressure Hydrostatic pressure 90 cIn Elution rate = 12 g/hr The resulting chromatogram is shown in FIG. 1 in Figure 4,
2 and 3 have the same meaning as in FIG.

実施例4 試料調製例3で得られた試料の半量を用いた他は実施例
3と同様にしてリボヌクレアーゼAによる消化とToy
opearl (登録商標:前出)によるゲル濾過を行
った。得られたクロマトグラムを第5図に示す。第5図
中1,2及び3は第1図中でのそれらと同じ意味を表わ
す。
Example 4 Digestion with ribonuclease A and Toy were carried out in the same manner as in Example 3 except that half of the sample obtained in Sample Preparation Example 3 was used.
Gel filtration was performed using opearl (registered trademark: supra). The obtained chromatogram is shown in FIG. 1, 2 and 3 in FIG. 5 have the same meanings as in FIG.

実施例5及び6 溶出液の塩化ナトリウム濃度を200 mM (実施例
5)及び300 mM (実施例6)としたほかは実施
例4と同様にしてリボヌクレアーゼ消化とデルp過を行
った。得られ念りロマトダラムを第6図(実施例5)及
び第7図(実施例6)に示す。両図中1,2及び3は第
1図中のそれらと同じ意味を表わす。
Examples 5 and 6 Ribonuclease digestion and Delp filtration were performed in the same manner as in Example 4, except that the sodium chloride concentration of the eluate was changed to 200 mM (Example 5) and 300 mM (Example 6). The obtained romatodalum is shown in FIG. 6 (Example 5) and FIG. 7 (Example 6). 1, 2 and 3 in both figures represent the same meanings as those in FIG.

実施例7 20 mM )リス塩酸塩、200 mM NaCt、
  1 mMEDTA 、 pH7,4の緩衝液で平衡
化させた陰イオン交換セルロース(DEAEセルロース
(Whatman DI52、商標))0.7mをカラ
ムに・臂ツクし、実施例4ないし6で得られたプラスミ
ドDNAの画分を合併しく合量80+++j)を通過さ
せ、DNAを吸着させた。
Example 7 20mM) Liss hydrochloride, 200mM NaCt,
0.7 m of anion exchange cellulose (DEAE cellulose (Whatman DI52, trademark)) equilibrated with 1 mM EDTA, pH 7.4 buffer was applied to the column, and the plasmid DNA obtained in Examples 4 to 6 was added to the column. A total amount of 80+++j) of the fractions was passed through the tube to adsorb DNA.

カラムを同緩衝液40t/で洗りた後、20 mM )
 IJス塩酸塩、1 mMNaCt、 1 mM ED
TA 、 pH7,4の緩衝液5dで溶出した。溶出液
をエタノール沈殿(2回)させ、エタノールでリンスし
た後、真空乾燥し、500fitf)TE緩衝液に溶解
したa 260 nmにおける吸光度から算出した収量
は、約420μ9であった。
After washing the column with 40t of the same buffer, 20mM)
IJS hydrochloride, 1mM NaCt, 1mM ED
Elution was performed with TA, pH 7.4 buffer 5d. The eluate was precipitated with ethanol (twice), rinsed with ethanol, dried under vacuum, and dissolved in TE buffer (500 fitf).The yield calculated from the absorbance at 260 nm was about 420 μ9.

試料調製例1 プラスミドpBR322を持つ大腸菌、ニジエリシャコ
リ HBIOI株(B、 coli HB 101/p
BR322)をアンピシリン25μm1/IrLlを含
むLB培地で前培養し、これを同培地1!!に0.5チ
接種し、37℃で9時間振盪培養を行った。培養終了後
遠心分離によって菌体を集め、これに20 mM )リ
ス塩酸塩、100 mM NaC1、5mM EDTA
を含むpH7,5の緩衝液8Mを加え、混合した。
Sample Preparation Example 1 Escherichia coli carrying plasmid pBR322, B. coli HBIOI strain (B, coli HB 101/p
BR322) was precultured in LB medium containing 25 μm1/IrLl of ampicillin, and this was cultured in the same medium 1! ! was inoculated at 0.5 inch, and cultured with shaking at 37°C for 9 hours. After completion of the culture, the bacterial cells were collected by centrifugation, and added with 20mM Liss hydrochloride, 100mM NaCl, 5mM EDTA.
8M buffer containing pH 7.5 was added and mixed.

これに8係シヨ糖、5%トリトンX−100゜50 m
M EDTA 、 50 mM )リス塩酸塩を含むp
)18.0の緩衝液70rnlを加えて混合した後、リ
ゾチーム溶液(10Tn9/lutの濃度になる様に、
リゾチームを10 mM )リス塩酸塩及び1 mM 
EDTAを含むPI(s、 。
Add to this 8-group sucrose, 5% Triton X-100゜50 m
MEDTA, 50 mM) p containing lithium hydrochloride
) After adding and mixing 70rnl of 18.0 buffer solution, add lysozyme solution (so that the concentration is 10Tn9/lut,
10 mM lysozyme) lys hydrochloride and 1 mM
PI(s, ) containing EDTA.

の緩衝液に溶解したもの)5dを加えた。得られた溶液
をゆるやかに攪拌しながら75秒間沸騰水中で熱処理を
行った。これを急冷後遠心分離し、上清にイソプロ・9
ノール50dを加えて混合し、−20℃で30分間靜隠
した。遠心分離によって沈殿を集め、これに0.3 M
酢酸ナトリウム溶液7、5 rILtを加えて混合し、
遠心分離によって不溶物を除去した。
(dissolved in the buffer solution) 5d was added. The resulting solution was heat-treated in boiling water for 75 seconds while being gently stirred. After quenching this, centrifuge it and add isopro-9 to the supernatant.
Nol 50d was added, mixed and kept at -20°C for 30 minutes. Collect the precipitate by centrifugation and add 0.3 M
Add sodium acetate solution 7,5 rILt and mix;
Insoluble matter was removed by centrifugation.

これに20rILtのエタノールを加え、混合後−20
℃で一夜放置し九。
Add 20 rILt of ethanol to this, and after mixing -20
Leave overnight at 9°C.

遠心分離によって沈殿を集め、さらにエタノールリンス
の後、真空乾燥を行って本発明の出発試料を得た。
The precipitate was collected by centrifugation, rinsed with ethanol, and vacuum dried to obtain a starting sample for the present invention.

試料調製例2および3 !ラスミドpBR322を持つニジエリシャコリHB1
01株に代えて、プラスミドpUC8(試料調製例2)
およびpUC9(試料調製例3)を持つ大腸菌、ニジエ
リシャコリJM83株(E、 coil JM83/p
UC8及びE、 coli JM83/pUC9)を用
いて試料調製例1と同様にして出発試料の調製を行い、
それぞれ相通する試料を得た。これらのシラスミドはジ
ーン(Vieira、 J* et al、、 Gon
e )、19巻、259頁(1982)に開示されてい
る。
Sample preparation examples 2 and 3! Nijieri shakori HB1 with lasmid pBR322
Plasmid pUC8 (Sample Preparation Example 2) in place of the 01 strain
and pUC9 (Sample Preparation Example 3), E. coli strain JM83 (E, coil JM83/p
A starting sample was prepared in the same manner as in Sample Preparation Example 1 using UC8 and E. coli JM83/pUC9).
Compatible samples were obtained for each. These cilasmids have been described by Gene (Vieira, J* et al., Gon
e), Vol. 19, p. 259 (1982).

〔発明の効果〕〔Effect of the invention〕

本発明によれば従来、技術で困難であったシラスミドD
NA画分への染色体DNAの混入をほとんど阻止するこ
とができる。
According to the present invention, cilasmid D, which has been difficult to obtain with conventional technology,
Contamination of chromosomal DNA into the NA fraction can be almost completely prevented.

また本発明によれば従来技術に比べ短時間かつ経済的に
高純度のプラスミドDNAを得ることができる。
Furthermore, according to the present invention, highly purified plasmid DNA can be obtained in a shorter time and more economically than with conventional techniques.

【図面の簡単な説明】[Brief explanation of drawings]

第1図、及び第3図ないし第7図は本発明によってプラ
スミドDNAの分離精製を行った際のクロマトグラムを
示す図であり、第2図はクロマトグラフィで得られた画
分のアガロース電気泳動/4’タンを示す図である。 「“− 新部興治1、C 第1区 第3図 筋4図 第5図 第6図 1nう同 田456幡地
FIG. 1 and FIGS. 3 to 7 are diagrams showing chromatograms obtained when plasmid DNA was separated and purified according to the present invention, and FIG. 2 shows agarose electrophoresis/ It is a figure showing a 4' tongue. ""- Shinbe Koji 1, C 1st ward, Figure 3, Line 4, Figure 5, Figure 6, 1n, Doda 456 Hatchi

Claims (4)

【特許請求の範囲】[Claims] (1)共存成分としてRNA及び他のDNAを含む環状
二重鎖DNAを、トリス塩酸塩、EDTA及び塩化ナト
リウムを含むpH約7.0ないし約8.5の水性展開液
を用いて、側鎖にヒドロキシル基及びエーテル結合を有
し、水溶液中で膨潤する親水性半硬質架橋ビニルポリマ
ーゲル上でゲルろ過クロマトグラフィに付することを特
徴とするプラスミドDNAの分離精製方法。
(1) Cyclic double-stranded DNA containing RNA and other DNA as coexisting components is prepared using an aqueous developing solution containing Tris hydrochloride, EDTA, and sodium chloride with a pH of about 7.0 to about 8.5. 1. A method for separating and purifying plasmid DNA, which comprises subjecting it to gel filtration chromatography on a hydrophilic semi-rigid crosslinked vinyl polymer gel that has hydroxyl groups and ether bonds and swells in an aqueous solution.
(2)精製分離されるプラスミドDNAの大きさが約3
ないし約12kbpである特許請求の範囲第(1)項記
載の分離精製方法。
(2) The size of the plasmid DNA to be purified and separated is approximately 3
12 kbp to about 12 kbp.
(3)用いる親水性半硬質ビニルポリマーゲルが約1,
000Å以上の巨大平均細孔径と約100μm以下の平
均粒子径を有する球状ゲルである特許請求の範囲第(1
)項又は第(2)項記載の分離精製方法。
(3) The hydrophilic semi-rigid vinyl polymer gel used is approximately 1,
Claim 1 which is a spherical gel having a giant average pore diameter of 000 Å or more and an average particle diameter of about 100 μm or less
) or (2).
(4)あらかじめRNAの少なくとも一部をリボヌクレ
アーゼで消化したのちゲルろ過クロマトグラフィに付す
る、特許請求の範囲第(1)項ないし第(3)項のいず
れかの項記載の分離精製方法。
(4) The separation and purification method according to any one of claims (1) to (3), wherein at least a portion of the RNA is previously digested with ribonuclease and then subjected to gel filtration chromatography.
JP60027419A 1985-02-14 1985-02-14 Plasmid DNA separation and purification method Pending JPS61187793A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60027419A JPS61187793A (en) 1985-02-14 1985-02-14 Plasmid DNA separation and purification method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60027419A JPS61187793A (en) 1985-02-14 1985-02-14 Plasmid DNA separation and purification method

Publications (1)

Publication Number Publication Date
JPS61187793A true JPS61187793A (en) 1986-08-21

Family

ID=12220571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60027419A Pending JPS61187793A (en) 1985-02-14 1985-02-14 Plasmid DNA separation and purification method

Country Status (1)

Country Link
JP (1) JPS61187793A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63150294A (en) * 1986-11-22 1988-06-22 キアゲン・ゲーエムベーハー Separation of long chain nucleic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63150294A (en) * 1986-11-22 1988-06-22 キアゲン・ゲーエムベーハー Separation of long chain nucleic acid

Similar Documents

Publication Publication Date Title
Allegra et al. Affinity chromatographic purification of nucleosomes containing transcriptionally active DNA sequences
EP2066792B1 (en) Nucleic acid purification method using anion exchange
CA2277165C (en) Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation
JP2721699B2 (en) Purification of hepatitis protein
JP3379758B2 (en) Enhancement of transfection efficiency of nucleic acid using aqueous solution containing isopropanol
EP2069495B1 (en) Nucleic acid purification method
EP0969090A1 (en) Rapid and simple process for isolation of circular nucleic acids
JP3438735B2 (en) Method for isolating human albumin from supernatant IV, especially IV-4 or corn fraction V or a similar supernatant or fraction
WO2008039669A1 (en) Nucleic acid purification method
US6441160B2 (en) Separating plasmids from contaminants using hydrophobic or hydrophobic and ion exchange chromatography
JP2022523389A (en) Purification process for biological molecules using anion exchange chromatography, such as plasmid DNA
JP4081376B2 (en) Isolation of DNA molecules
CN112063643A (en) Expression vector and method for detecting interaction of membrane proteins in bacteria
CN111448315B (en) Method for separating DNA by Cas protein system
JP4537070B2 (en) Separation using aromatic thioether ligands
Jervis et al. Purification of ribonuclease T1 on porous glass affinity adsorbents
JPS61187793A (en) Plasmid DNA separation and purification method
JPS62259596A (en) Purification of hybrid protein
Jakobi et al. Filter-supported preparation of λ phage DNA
Kondo et al. Rapid isolation of plasmid DNA by LiCl-ethidium bromide treatment and gel filtration
SU1076445A1 (en) Method for isolating polynucleotide phosphorilase
Monier et al. [53] Isolation and characterization of 5 S RNA from Escherichia coli
EP0059182B1 (en) A process for isolating aminoacylase enzyme from a mammal kidney extract
CN119876120A (en) Method for purifying plasmid DNA
WO1998023630A1 (en) Matrix for rapid purification of nucleic acids